Cipher Pharmaceuticals (CPH) News Today C$8.68 -0.13 (-1.48%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 13, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50-Day Moving Average of $8.65Cipher Pharmaceuticals (TSE:CPH) Shares Pass Below 50 Day Moving Average of $8.65June 27, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50-Day Moving Average of $8.72Cipher Pharmaceuticals (TSE:CPH) Shares Cross Below 50 Day Moving Average of $8.72May 30, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Crosses Above 50-Day Moving Average of $8.80Cipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50-Day Moving Average of $8.80May 22, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50 Day Moving Average of $8.70Cipher Pharmaceuticals (TSE:CPH) Stock Price Passes Above Fifty Day Moving Average of $8.70May 13, 2024 | finance.yahoo.comCipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50May 13, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Cut to Hold at Stifel NicolausStifel Nicolaus lowered shares of Cipher Pharmaceuticals from a "buy" rating to a "hold" rating and raised their price objective for the company from C$8.00 to C$9.50 in a research report on Monday.May 10, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High at $10.33Cipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $10.33May 6, 2024 | marketbeat.comCipher Pharmaceuticals (CPH) Scheduled to Post Quarterly Earnings on ThursdayCipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) will be releasing earnings after the market closes on Thursday, May 9, Zacks reports.April 28, 2024 | theglobeandmail.comCipher Pharmaceuticals: Stocks Overvalued by Analyst Consensus on TSX (CPH)April 27, 2024 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc flat on Friday (CPH)April 3, 2024 | ca.finance.yahoo.comStocks in play: Cipher PharmaceuticalsApril 1, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Shares Down 7.9% Cipher Pharmaceuticals (TSE:CPH) Stock Price Down 7.9%March 28, 2024 | theglobeandmail.comCipher Pharmaceuticals: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (CPH)March 21, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $9.17Cipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $9.17March 17, 2024 | investing.comEarnings call: Cipher Pharmaceuticals outlines growth and financialsMarch 17, 2024 | seekingalpha.comCipher Pharmaceuticals (CPHRF) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High After Better-Than-Expected EarningsCipher Pharmaceuticals (TSE:CPH) Hits New 52-Week High Following Strong EarningsMarch 11, 2024 | marketbeat.comCipher Pharmaceuticals (CPH) to Release Earnings on ThursdayCipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) will be releasing earnings after the market closes on Thursday, March 14, Zacks reports.March 6, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50-Day Moving Average of $6.37Cipher Pharmaceuticals (TSE:CPH) Share Price Crosses Above 50-Day Moving Average of $6.37February 14, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Passes Above Fifty Day Moving Average of $6.01Cipher Pharmaceuticals (TSE:CPH) Stock Passes Above Fifty Day Moving Average of $6.01February 5, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Sets New 1-Year High at $6.67Cipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $6.67January 5, 2024 | morningstar.comCipher Pharmaceuticals Inc CPHJanuary 3, 2024 | finance.yahoo.comCipher Pharmaceuticals Inc (PHE.MU)November 24, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Change of AuditorNovember 24, 2023 | benzinga.comCipher Pharmaceuticals Stock (OTC:CPHRF) Dividends: History, Yield and DatesNovember 15, 2023 | finance.yahoo.comCipher Pharmaceuticals Inc.'s (TSE:CPH) 23% gain last week benefited both individual investors who own 56% as well as insidersOctober 27, 2023 | finance.yahoo.comCipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference CallSeptember 5, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian DollarsAugust 10, 2023 | finance.yahoo.comCipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in MexicoJuly 28, 2023 | finance.yahoo.comCipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference CallJuly 5, 2023 | finance.yahoo.comCipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European UnionJune 21, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Results of Annual and Special Meeting of ShareholdersMay 4, 2023 | finance.yahoo.comCipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference CallApril 26, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc flat on Tuesday (CPH)April 20, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc flat on Thursday (CPH)April 18, 2023 | finanznachrichten.deBloom Burton & Co. Inc.: Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 18, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc up on Tuesday (CPH)April 18, 2023 | finance.yahoo.comCipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 14, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc up on Friday (CPH)April 10, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc down on Monday (CPH)April 6, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc down on Wednesday (CPH)March 19, 2023 | seekingalpha.comCipher Pharmaceuticals Non-GAAP EPS of -$0.12March 16, 2023 | finance.yahoo.comCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 1, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Closing of New US$35 Million Credit FacilityDecember 21, 2022 | seekingalpha.comCPH:CA Cipher Pharmaceuticals Inc.December 4, 2022 | finance.yahoo.comCipher Pharmaceuticals Inc.'s (TSE:CPH) Stock Is Going Strong: Have Financials A Role To Play?November 13, 2022 | finance.yahoo.comCipher Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagSeptember 14, 2022 | baystreet.caSigna, Boardwalktech, Cipher at 52-Week HighsAugust 5, 2022 | finance.yahoo.comCipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference CallJune 22, 2022 | finance.yahoo.comCipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia insiders dumping shares (Ad)All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can. To see Porter Stansberry's new AI prediction go here now. CPH Media Mentions By Week CPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPH News Sentiment▼0.000.62▲Average Medical News Sentiment CPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPH Articles This Week▼00▲CPH Articles Average Week Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: WEED News GUD News ACB News OGI News CRDL News RX News HLS News CWEB News LABS News DB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CPH) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cipher Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cipher Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.